Integrating knowledge and omics to decipher mechanisms via large‐scale models of signaling networks

M Garrido‐Rodriguez, K Zirngibl, O Ivanova… - Molecular systems …, 2022 - embopress.org
Signal transduction governs cellular behavior, and its dysregulation often leads to human
disease. To understand this process, we can use network models based on prior …

[PDF][PDF] A community challenge for a pancancer drug mechanism of action inference from perturbational profile data

EF Douglass, RJ Allaway, B Szalai, W Wang, T Tian… - Cell Reports …, 2022 - cell.com
Summary The Columbia Cancer Target Discovery and Development (CTD2) Center is
developing PANACEA, a resource comprising dose-responses and RNA sequencing (RNA …

Gene regulatory networks in disease and ageing

P Unger Avila, T Padvitski, AC Leote, H Chen… - Nature Reviews …, 2024 - nature.com
The precise control of gene expression is required for the maintenance of cellular
homeostasis and proper cellular function, and the declining control of gene expression with …

Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA …

RR Madsen, EC Erickson, OM Rueda, X Robin… - PLoS …, 2021 - journals.plos.org
A PI3Kα-selective inhibitor has recently been approved for use in breast tumors harboring
mutations in PIK3CA, the gene encoding p110α. Preclinical studies have suggested that the …

Predicting mechanism of action of novel compounds using compound structure and transcriptomic signature coembedding

G Jang, S Park, S Lee, S Kim, S Park, J Kang - Bioinformatics, 2021 - academic.oup.com
Motivation Identifying mechanism of actions (MoA) of novel compounds is crucial in drug
discovery. Careful understanding of MoA can avoid potential side effects of drug candidates …

Benchmarking causal reasoning algorithms for gene expression-based compound mechanism of action analysis

L Hosseini-Gerami, IA Higgins, DA Collier, E Laing… - BMC …, 2023 - Springer
Background Elucidating compound mechanism of action (MoA) is beneficial to drug
discovery, but in practice often represents a significant challenge. Causal Reasoning …

Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition

ML Burtscher, S Gade… - Molecular Systems …, 2024 - embopress.org
Complex disease phenotypes often span multiple molecular processes. Functional
characterization of these processes can shed light on disease mechanisms and drug effects …

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, A Valdeolivas, DJ Tóth… - PLoS computational …, 2022 - journals.plos.org
Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-
induced gene expression signatures is a promising bioinformatic tool to repurpose existing …

Characterization of type 1 angiotensin II receptor activation induced dual-specificity MAPK phosphatase gene expression changes in rat vascular smooth muscle cells

JB Gém, KB Kovács, L Szalai, G Szakadáti, E Porkoláb… - Cells, 2021 - mdpi.com
Activation of the type I angiotensin receptor (AT1-R) in vascular smooth muscle cells
(VSMCs) plays a crucial role in the regulation of blood pressure; however, it is also …

[HTML][HTML] Signatures of discriminative copy number aberrations in 31 cancer subtypes

B Gao, M Baudis - Frontiers in genetics, 2021 - frontiersin.org
Copy number aberrations (CNA) are one of the most important classes of genomic mutations
related to oncogenetic effects. In the past three decades, a vast amount of CNA data has …